Journal
Frontiers in Oncology
Publication Date
1-1-2021
Volume
11
First Page
762523
Document Type
Open Access Publication
DOI
10.3389/fonc.2021.762523
Rights and Permissions
Lu Y, Xin D, Guan L, Xu M, Yang Y, Chen Y, Yang Y, Wang-Gillam A, Wang L, Zong S and Wang F (2021) Metformin Downregulates PD-L1 Expression in Esophageal Squamous Cell Carcinoma by Inhibiting IL-6 Signaling Pathway. Front. Oncol. 11:762523. doi: 10.3389/fonc.2021.762523 © 2021 Lu, Xin, Guan, Xu, Yang, Chen, Yang, Wang-Gillam, Wang, Zong and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Recommended Citation
Lu, Yao; Xin, Dao; Guan, Lulu; Xu, Mengli; Yang, Yalan; Chen, Yu; Yang, Yuanyuan; Wang-Gillam, Andrea; Wang, Li; Zong, Shanggang; and Wang, Feng, "Metformin downregulates PD-L1 expression in esophageal squamous cell catrcinoma by inhibiting IL-6 signaling pathway." Frontiers in Oncology. 11, 762523 (2021).
https://digitalcommons.wustl.edu/open_access_pubs/11485
Supplementary Table 1 and Supplementary Figures 1 and 2
